Vendela Parrow

505 total citations
18 papers, 341 citations indexed

About

Vendela Parrow is a scholar working on Molecular Biology, Organic Chemistry and Hematology. According to data from OpenAlex, Vendela Parrow has authored 18 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 3 papers in Organic Chemistry and 3 papers in Hematology. Recurrent topics in Vendela Parrow's work include Acute Myeloid Leukemia Research (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Neuroblastoma Research and Treatments (2 papers). Vendela Parrow is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Neuroblastoma Research and Treatments (2 papers). Vendela Parrow collaborates with scholars based in Sweden, United States and United Kingdom. Vendela Parrow's co-authors include Sven Påhlman, Eewa Nånberg, Erik Lavenius, Ulf Hammerling, Jari Heikkilä, Peter Aleström, Rolf Larsson, Kaare M. Gautvik, Christer Betsholtz and Malin Jarvius and has published in prestigious journals such as Cancer Research, Scientific Reports and Journal of Cell Science.

In The Last Decade

Vendela Parrow

18 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vendela Parrow Sweden 12 222 79 48 46 42 18 341
Kiran Kodali United States 10 272 1.2× 79 1.0× 43 0.9× 46 1.0× 28 0.7× 12 399
Takazumi Taniguchi Japan 15 257 1.2× 24 0.3× 58 1.2× 29 0.6× 28 0.7× 25 660
Pascal St-Pierre Canada 7 355 1.6× 39 0.5× 157 3.3× 35 0.8× 23 0.5× 7 468
Zhongzong Pan United States 10 302 1.4× 48 0.6× 54 1.1× 36 0.8× 79 1.9× 14 469
Dorothy H. Crouch United Kingdom 11 272 1.2× 25 0.3× 86 1.8× 46 1.0× 46 1.1× 15 402
Mario Buono United Kingdom 10 178 0.8× 36 0.5× 90 1.9× 16 0.3× 28 0.7× 14 388
Chihana Kabuta Japan 9 200 0.9× 47 0.6× 40 0.8× 36 0.8× 19 0.5× 13 303
Mai Tsuchiya Japan 10 247 1.1× 36 0.5× 34 0.7× 40 0.9× 73 1.7× 29 367
Laura A. Tollini United States 7 237 1.1× 34 0.4× 33 0.7× 96 2.1× 102 2.4× 9 355
Ratnakar Patti United States 10 216 1.0× 42 0.5× 15 0.3× 74 1.6× 86 2.0× 10 366

Countries citing papers authored by Vendela Parrow

Since Specialization
Citations

This map shows the geographic impact of Vendela Parrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vendela Parrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vendela Parrow more than expected).

Fields of papers citing papers by Vendela Parrow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vendela Parrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vendela Parrow. The network helps show where Vendela Parrow may publish in the future.

Co-authorship network of co-authors of Vendela Parrow

This figure shows the co-authorship network connecting the top 25 collaborators of Vendela Parrow. A scholar is included among the top collaborators of Vendela Parrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vendela Parrow. Vendela Parrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Geitmann, Matthis, Peter Brandt, Ulf Bremberg, et al.. (2023). Abstract 705: Potentiation of immunotherapy by LSD1 modulation. Cancer Research. 83(7_Supplement). 705–705. 2 indexed citations
2.
Andersson, Claes, Jenny Rubin, Malin Berglund, et al.. (2020). Mebendazole is unique among tubulin-active drugs in activating the MEK–ERK pathway. Scientific Reports. 10(1). 13124–13124. 12 indexed citations
3.
Rubin, Jenny, Malin Berglund, Malin Jarvius, et al.. (2019). Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibition. BMC Research Notes. 12(1). 234–234. 18 indexed citations
4.
Geitmann, Matthis, Malin Jarvius, Konrad F. Koehler, et al.. (2019). Abstract 3843: LSD1 modulation by allosteric ligands. Cancer Research. 79(13_Supplement). 3843–3843. 3 indexed citations
5.
Senkowski, Wojciech, Malin Jarvius, Malin Berglund, et al.. (2017). The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activation. Immunopharmacology and Immunotoxicology. 39(4). 199–210. 23 indexed citations
6.
Akopyan, Karen, Vendela Parrow, Thomas Strömberg, et al.. (2014). Picropodophyllin causes mitotic arrest and catastrophe by depolymerizing microtubules via Insulin-like growth factor-1 receptor-independent mechanism. Oncotarget. 5(18). 8379–8392. 20 indexed citations
7.
Eriksson, Anna, Antonia Kalushkova, Malin Jarvius, et al.. (2013). AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and dose dependent reduction of tyrosine kinase activity in acute myeloid leukemia. Biochemical Pharmacology. 87(2). 284–291. 12 indexed citations
8.
Eriksson, Anna, Monica Hermanson, Malin Wickström, et al.. (2012). The novel tyrosine kinase inhibitor AKN-028 has significant antileukemic activity in cell lines and primary cultures of acute myeloid leukemia. Blood Cancer Journal. 2(8). e81–e81. 14 indexed citations
9.
Eriksson, Anna, Martin Höglund, Elin Lindhagen, et al.. (2010). Identification of AKN-032, a novel 2-aminopyrazine tyrosine kinase inhibitor, with significant preclinical activity in acute myeloid leukemia. Biochemical Pharmacology. 80(10). 1507–1516. 7 indexed citations
10.
Parrow, Vendela, et al.. (2006). In vivo evaluation of a novel, orally bioavailable, small molecule growth hormone receptor antagonist. Growth Hormone & IGF Research. 17(1). 47–53. 7 indexed citations
11.
Chmielewska, Joanna, et al.. (2005). Antisense and Sense RNA Probe Hybridization to Immobilized Crude Cellular Lysates: A Tool to Screen Growth Hormone Antagonists. SLAS DISCOVERY. 10(3). 260–269. 6 indexed citations
12.
Parrow, Vendela, Claire E. Horton, Malcolm Maden, S. Laurie, & Elena Notarianni. (1998). Retinoids are endogenous to the porcine blastocyst and secreted by trophectoderm cells at functionally-active levels. The International Journal of Developmental Biology. 42(4). 629–632. 21 indexed citations
13.
Parrow, Vendela, et al.. (1995). Protein kinase C‐α and ‐ε are enriched in growth cones of differentiating SH‐SY5Y human neuroblastoma cells. Journal of Neuroscience Research. 41(6). 782–791. 29 indexed citations
14.
Parrow, Vendela, et al.. (1994). Protein synthesis and mRNA in isolated growth cones from differentiating SH‐SY5Y neuroblastoma cells. Journal of Neuroscience Research. 37(3). 303–312. 4 indexed citations
15.
Lavenius, Erik, Vendela Parrow, Eewa Nånberg, & Sven Påhlman. (1994). Basic FGF and IGF-I Promote Differentiation of Human SH-SY5Y Neuroblastoma Cells in Culture. Growth Factors. 10(1). 29–39. 67 indexed citations
16.
Påhlman, Sven, et al.. (1993). Human GAP-43 Gene Expression: Multiple Start Sites for Initiation of Transcription in Differentiating Human Neuroblastoma Cells. Molecular and Cellular Neuroscience. 4(6). 549–561. 35 indexed citations
17.
Parrow, Vendela, Eewa Nånberg, Jari Heikkilä, Ulf Hammerling, & Sven Påhlman. (1992). Protein kinase C remains functionally active during TPA induced neuronal differentiation of SH‐SY5Y human neuroblastoma cells. Journal of Cellular Physiology. 152(3). 536–544. 41 indexed citations
18.
Parrow, Vendela, Peter Aleström, & Kaare M. Gautvik. (1989). 5-Azacytidine-induced alterations in the GH12C1 cells: effects on cellular morphology, chromosome structure, DNA and protein synthesis. Journal of Cell Science. 93(3). 533–543. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kiran Kodali Breakdown of academic impact, for papers by Takazumi Taniguchi Breakdown of academic impact, for papers by Pascal St-Pierre Breakdown of academic impact, for papers by Zhongzong Pan Breakdown of academic impact, for papers by Dorothy H. Crouch Breakdown of academic impact, for papers by Mario Buono Breakdown of academic impact, for papers by Chihana Kabuta Breakdown of academic impact, for papers by Mai Tsuchiya Breakdown of academic impact, for papers by Laura A. Tollini Breakdown of academic impact, for papers by Ratnakar Patti
Rankless by CCL
2026